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.4bstract 
We have investigated levels of antioxidant enzymes and free radical-induced DNA base modifications in human cancerous lung tissues and in their 
cancer-free surrounding tissues. Various DNA base lesions in chromatin of lung tissues were measured by gas chromatography-mass pectrometry. 
.4ctivities of superoxide dismutase, catalase and glutathione peroxidase were also measured in lung tissues. Higher levels of DNA lesions were observed 
m cancerous tissues than in cancer-free surrounding tissues. Antioxidant enzyme levels were lower in cancerous tissues. The results indicate an 
association between decreased activities of antioxidant enzymes and increased levels of DNA lesions in cancerous tissues. Higher levels of DNA lesions 
suggest hat free radical reactions may be increased in malignant umor cells. 
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1. Introduction 
DNA damage is thought to be involved in all stages 
of carcinogenesis (reviewed in [1,2]). Thus any agent ca- 
pable of chemically modifying DNA in cells could be 
carcinogenic. Oxygen-derived free radicals formed in 
cells by endogenous and exogenous ources may modify 
cellular components including DNA by a variety of 
mechanisms (reviewed in [3]). Free radicals, most nota- 
bly hydroxyl radical (‘OH), can cause extensive chemical 
modifications in DNA and nucleoprotein, including 
modified bases, modified sugars, strand breaks and 
DNA-protein cross-links (reviewed in [3-61). Thus free 
radicals may be mutagenic and carcinogenic. 
Antioxidant enzymes exist in cells to protect against 
the toxic effects of oxygen-derived species produced dur- 
mg normal cellular metabolism or during oxidative stress 
(reviewed in [7]). These antioxidant enzymes include su- 
*Corresponding author. Fax: (1) (301) 330-3447. 
.4bbrevations: O’;, superoxide radical; ‘OH, hydroxyl radical; 5-OH- 
Hyd, 5-hydroxyhydantoin; 5-OH-5-MeHyd, 5-hydroxy-5-methylhy- 
dantoin; Thy glycol, thyrnine glycol; 5-OHMe-Ura, 5-(hydroxy- 
methyl)uracil; 5-OH-Ura, 5-hydroxyuracil; 5-OH-Cyt, 5-hydroxycyto- 
sine; 5,6-diOH-Ura, 5,6-dihydroxyuracil; 2-OH-Ade, 2-hydroxyaden- 
ine; 8-OH-Ade, 8-hydroxyadenine; FapyAde, 4,6-diamino-5-formami- 
dopyrimidine; 8-OH-Gua, I-hydroxyguanine; FapyGua, 2,6-diamino- 
J-hydroxy-5-formamidopyrimidine; GC/MS-SIM, gas chromatogra- 
phy-mass pectroscopy with selected-ion monitoring; GPx, glutathione 
peroxidase; SOD, superoxide dismutase; CAT, catalase. 
peroxide dismutase (SOD), catalase (CAT) and glutathi- 
one peroxidase (GPx). Tumor cells have been shown to 
have abnormal evels of antioxidant enzymes and activi- 
ties when compared with normal cells [7]. However, anti- 
oxidant enzyme activities also differ among individual 
tumors. 
Typical free radical-induced DNA base modifications 
in cancerous human tissues have been investigated re- 
cently [8,9]. However, no insight has been provided thus 
far, regarding a possible relationship between these mod- 
ifications and antioxidant enzyme activities in cancerous 
tissues and in surrounding cancer-free tissues. In the 
present work, we have investigated DNA base modifica- 
tions and antioxidant enzyme activities in normal and 
cancerous human lung tissues to check whether an asso- 
ciation exists between these two possibly important fac- 
tors in cancer. 
2. Materials and methods 
2.1. Materials, human tissues, measurement of enzyme activities and 
isolation of chromatin 
Certain commercial equipment or materials are identified in this 
paper in order to specify adequately the experimental procedure. Such 
identification does not imply recommendation or endorsement by the 
National Institute of Standards and Technology, nor does it imply that 
the materials or equipment identified are necessarily the best available 
for the purpose. 
Materials were as described previously [lo]. The human tissues were 
obtained from Department of Surgery, Medical School, Gdansk, Po- 
land, during surgery on five lung cancer patients. Approximately 0.7- 
1.2 g of tissues were collected for chromatin isolation and measurement 
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of enzyme activities. After surgical removal, all tissues were quickly 
frozen and stored in liquid nitrogen. Histopathological evaluation of 
surgically removed tissues revealed that the surgical margins (removed 
from the most distant part of the lung which had no connection to the 
cancer) were disease-free while the affected tissues exhibited lung 
squamous cell carcinoma. Every tissue sample was divided into three 
separate parts, transferred to a Potter homogenizer and disrupted with 
several strokes of first loose and then a tighter pestle in 10 ml of 20 mM 
phosphate buffer @H 7.4), containing 0.1 mM phenylmethanesulfonyl 
fluoride. An aliquot (6 ml) of the resulting homogenate was used for 
chromatin isolation [9,1 l]. Another aliquot (4 ml) was used to assay 
antioxidant enzyme activity. Catalase was assayed by a calorimetric 
method using dichromate/acetic acid 1121. The total activity of SOD 
(CuZnSOD &d MnSOD) was measured using xanthine-xanthine oxi- 
dase system with Nitroblue tetrazolium [13]. The activity of Se-GPx was 
assayed using t-butylhydroperoxide as a substrate [14]. Protein content 
in tissue extracts was determined according to Smith et al. [15]. 
2.2. Hydrolysis, derivatization and gas chromatographylmass 
spectrometry 
Chromatin samples containing 100 rug DNA were hydrolyzed and 
trimethylsilylated, and subsequently analyzed by gas chromatography- 
mass spectrometry with selected-ion monitoring (GUMS-SIM) as de- 
scribed previously [9,10,16]. The quantification of products was done 
by isotope-dilution mass spectrometry using their stable isotope-labeled 
analogues as internal standards [10,17]. 
3. Results 
The aim of this study was to examine endogenous 
levels of typical free radical-induced DNA bases and 
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antioxidant enzyme activities in human cancerous lung 
tissues and their cancer-free surrounding tissues. Chemi- 
cal characterization and quantification of free radical- 
modified DNA bases in DNA or in chromatin can be 
achieved by GC/MS [l&19]. To this end, various DNA 
lesions derived from all four DNA bases are measured 
using the same DNA or chromatin sample. 
Tissues samples were removed surgically from five 
lung cancer patients. All patients were heavy smokers. 
We were unable to find any nonsmoker patient among 
lung cancer patients examined in the clinic of Medical 
School in Gdansk, Poland. Twelve modified bases were 
identified and quantified in chromatin samples isolated 
from cancerous tissues and their cancer-free surrounding 
tissues. These were 5-OH-Hyd, 5-OH-5-MeHyd, Thy 
glycol, 5-OHMe-Ura, 5-OH-Ura, 5-OH-Cyt, 5,6-diOH- 
Ura, 2-OH-Ade, 8-OH-Ade, FapyAde, 8-OH-Gua and 
FapyGua. The quantities of these modified DNA bases 
in lung tissues are shown in Fig. 1. For each of the data 
points shown in Fig. 1, three independent measurements 
were carried out using chromatin samples isolated from 
three separate tissue samples taken from the same can- 
cerous tissue or surrounding cancer-free tissue. Aliquots 
of the same tissues samples were used to measure the 
activities of SOD, CAT and GPx. The results are illus- 
trated in Fig. 2. 
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Fig. 1. Amounts of modified DNA bases in human cancerous lung tissues and their surrounding cancer-free tissues. Each data point represents the 
mean + S.D. from measurement of chromatin samples isolated from three separate tissue samples (1 nmol of a modified base/mg of DNA = 32 
molecules of a modified base/lo’ DNA bases). 
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Fig. 1. (Continued). 
62 P Jaruga et al. IFEBS Letters 341 (1994) 59-64 
Fig. 2. Activities of GPx, SOD and CAT in human cancerous lung tissues and their surrounding cancer-free tissues. Each data point represents the 
mean f S.D. from three independent measurements. 
The amounts of modified bases that were measured in 
cancer-free lung tissues varied depending on the individ- 
uals (Fig. 1). Increased amounts of %OH-Ade were ob- 
served in cancerous tissues of all five patients (Fig. 11) 
whereas four patients had increased amounts of S-OH- 
Gua in their cancerous tissues (Fig. 1 K). FapyGua could 
be quantified in tissues of three patients only, and its 
amount was higher in cancerous tissues than in cancer- 
free tissues in all cases (Fig. 1L). The amounts of 5- 
OHMe-Ura, 5-OH-Ura, 5-OH-Cyt and 2-OH-Ade were 
higher in cancerous tissues of three patients (Fig. lD, E, 
F and H). Increased amounts of 5-OH-Hyd, Thy glycol, 
5,6-diOH-Ura and FapyAde were observed in cancerous 
tissues of one or two patients only (Fig. lA, C, G 
and J). 
In the case of all five patients, the activities of the 
enzymes GPx, SOD and CAT were found to be de- 
creased in cancerous tissues with respect to their sur- 
rounding cancer-free tissues (Fig. 2). The highest de- 
crease was observed in the activity of GPx, which 
amounted to = 2- to 3-fold (Fig. 2A). The activity of 
SOD in cancerous tissues was also significantly lower 
than in normal tissues (Fig. 2B). Only a modest decrease 
in the CAT activity was observed (Fig. 2C). 
4. Discussion 
The results of this work show higher endogenous lev- 
els of typical ‘OH-induced products of all four DNA 
bases and lower activities of antioxidant enzymes in 
human cancerous lung tissues than in their respective 
surrounding cancer-free tissues. These results are consis- 
tent with our earlier observations of higher levels of py- 
rimidine- and purine-derived DNA lesions in different 
human cancerous tissues [9]. However, a possible associ- 
ation between increased levels of modified DNA bases 
and decreased levels of antioxidant enzymes in human 
cancerous tissues with respect to cancer-free tissues is 
reported here for the first time. 
Patients whose tissues were examined in the present 
work were all smokers. Epidemiological studies have es- 
tablished smoking as the major cause of human lung 
cancer [20,21]. Cigarette smoke has been shown to cause 
DNA damage in cultured human lung cells [22]. Oxygen- 
derived species uch as Hz02 and superoxide radical (0’;) 
are known to be involved in causing DNA damage by 
cigarette smoke and tar, most likely by producing ‘OH 
in metal ion-catalyzed reactions (reviewed in [3,23,24]). 
H,Oa and 0.; alone do not produce any DNA damage 
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(reviewed in [3]). Furthermore, cigarette smoking de- 
pletes intracellular antioxidants and increases the num- 
ber of neutrophils in the lung, which are another source 
of oxygen-derived species (reviewed in [24]). 
Elevated levels of modified DNA bases in cancerous 
tissues may be due in part to the presence of large 
amounts of leukocytes in human tumors [25]. Activated 
leukocytes are a source of H,Oz, which can cross cellular 
and nuclear membranes, and reach the nucleus to cause 
site-specific DNA damage by producing ‘OH in reac- 
tions with DNA-bound metal ions (reviewed in [1,26]). 
Moreover, human tumor cells have been shown to pro- 
duce large amounts of H202 [27]. In fact, treatment of 
mammalian cells with H202 or with activated leukocytes 
causes modification of all four DNA bases with a pattern 
of modified bases similar to that observed in the present 
work [28,29]. 
In tumor cells, activities of antioxidant enzymes have 
been found to be generally lower than in normal cells, 
although GPx activities were found to be higher in some 
tumor cell lines with large interindividual variations (re- 
viewed in [7]). Our results showing lower activities of 
GPx, SOD and CAT in cancerous lung tissues are consis- 
tent with the general tendency of previous findings. 
Lower levels of antioxidant enzymes may cause the accu- 
mulation of H,O, and 0.; in tumor cells [7]. This may 
result in subsequent greater base damage to DNA in 
cancerous tissues as the findings of the present work 
indicate. Higher levels of typical ‘OH-induced DNA base 
lesions as observed here lends credence to the hypothesis 
that free radical reactions may be increased in malignant 
cells, concurrent with decreased antioxidant protection 
[301. 
It is not known whether lower levels of antioxidant 
enzymes in cancerous lung tissues play a causative role 
in carcinogenesis or are merely the result of the disease. 
The same is true of the pyrimidine- and purine-derived 
DNA lesions that were identified in cancerous tissues at 
higher levels than in cancer-free surrounding tissues. 
However, treatment of laboratory animals with carcino- 
genic agents causes formation of a similar pattern of 
pyrimidine- and purine-derived DNA lesions in their tar- 
get organs before tumor formation occurs [31-341. Fur- 
thermore, several lesions identified in this work have 
been found to possess mutagenic properties (reviewed in 
[35-37]), although the majority of these lesions has not 
been investigated for their biological consequences. All 
these data may indicate an important role for these DNA 
lesions in carcinogenesis. On the other hand, in fully 
developed cancer, increased levels of modified DNA 
bases may contribute to the genetic instability and metas- 
tatic potential of tumor cells. 
In conclusion, the present work provides evidence for 
a possible association between decreased activities of an- 
tioxidant enzymes and increased levels of pyrimidine- 
and purine-derived DNA lesions in human cancerous 
63 
lung tissues. Higher levels of DNA lesions indicate that 
free radical reactions may be increased in malignant 
cells. Higher levels of these lesions may contribute to 
the genetic instability and metastatic potential of tu- 
mors, and may be necessary for maintaining the malig- 
nancy. 
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